Moorfields Private has launched a specialist screening service for patients taking weight loss drugs following increased scrutiny of the potential eye health risks associated with GLP-1 medications. The service, aimed particularly at patients taking drugs such as Wegovy, Ozempic and Mounjaro for weight loss, will offer retinal imaging and specialist ophthalmology assessments outside the NHS…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
